Decrease in disease activity and concomitant increase in the percentage of peripheral blood suppressor T-cells in rheumatoid arthritis by a newly synthesized slow-acting anti-rheumatic drug (Bucillamine)

This publication has 15 references indexed in Scilit:

• T cytotoxic and helper cells are markedly increased, and t suppressor and inducer cells are markedly decreased, in rheumatoid synovial fluids
  Arthritis & Rheumatism, 1987
• Pharmacological studies on N-(2-mercapto-2-methylpropanoyl)-L-cysteine(SA96). IV. Effects of SA96 and its main metabolite, SA679, on denaturation of human .GAMMA.-globulin and adjuvant arthritis in rats.
  Folia Pharmacologica Japonica, 1985
• Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agents
  International Journal of Immunopharmacology, 1981
• GLUCOCORTICOID THERAPY
  Medicine, 1976
• Clinical Use of Immunosuppressive Drugs
  Drugs, 1976
• Penicillamine Therapy for Rheumatoid Lung Disease: Effects on Protein Sulphydryl Groups
  Nature, 1966
• The effect of penicillamine on the laboratory parameters in rheumatoid arthritis
  Arthritis & Rheumatism, 1965
• Rheumatoid Arthritis with Arteritis
  Annals of Internal Medicine, 1964
• QUANTITATION OF THE ACTIVITY OF RHEUMATOID ARTHRITIS 5. A METHOD FOR SUMMATION OF THE SYSTEMIC INDICES OF RHEUMATOID ACTIVITY
  The Lancet Healthy Longevity, 1956
• TREATMENT OF ARTHRITIS AND RHEUMATISM WITH GOLD
  The Lancet, 1934